Celularity Inc. - Class A (CELU) analyst actions
Rating and price-target actions on CELU in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CELU overview →
2 measured CELU analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities | Press release | +0.81% | +2.42% | |
| Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline | Press release | +1.10% | +19.05% |
Keep exploring
More CELU: earnings → · SEC filings → · CELU overview →